Pfizer gets three-year reprieve from planned tariffs, as it agrees to lower drug prices for Americans
Published on: Oct. 1, 2025, 3:05 a.m. | Source: Livemint
Trump announced a landmark deal with Pfizer granting the company a three-year reprieve from planned tariffs in exchange for voluntarily lowering US drug prices. Pfizer will offer most-favored-nation pricing for Medicaid and all new drugs, participate in the TrumpRx direct-to-consumer platform
